Slim Weight Loss Clinic

Slim Weight Loss Clinic operates in Portland, Oregon, providing medically supervised weight management programs centered on GLP-1 receptor agonist therapies. The clinic structures treatment around three FDA-approved peptide medications: liraglutide, semaglutide, and tirzepatide, each selected based on individual metabolic profiles, weight loss goals, and medical history. Patients undergo comprehensive initial assessments that include body composition analysis, metabolic panel review, and evaluation of comorbid conditions such as type 2 diabetes, hypertension, and sleep apnea before receiving peptide prescriptions.

The clinic's protocol begins with baseline laboratory work to establish kidney function, liver enzymes, and thyroid status before initiating GLP-1 therapy. Liraglutide treatment typically starts at 0.6 mg daily with weekly titration up to 3.0 mg, while semaglutide follows a monthly escalation schedule from 0.25 mg to maintenance doses of 1.0-2.4 mg weekly. Tirzepatide, the dual GIP/GLP-1 receptor agonist, begins at 2.5 mg weekly with increases every four weeks based on tolerance and response. Each medication requires specific injection technique training, which the Portland clinic provides during the first visit, along with printed protocols for managing common side effects like nausea, constipation, and injection site reactions.

Slim Weight Loss Clinic's medical team includes physicians trained in obesity medicine who conduct monthly follow-up appointments to monitor weight trends, adjust dosing, and address metabolic changes. These visits track more than scale weight—providers review blood pressure readings, fasting glucose levels, and patient-reported quality of life measures to assess comprehensive treatment response. The clinic does not offer telehealth services; all consultations occur at the Portland location, allowing for in-person physical examinations and immediate intervention if adverse effects develop. This face-to-face model enables providers to identify early signs of gallbladder complications, pancreatitis symptoms, or thyroid changes that require peptide discontinuation.

Patients at the Portland clinic receive structured nutritional guidance alongside peptide therapy, with meal planning focused on protein intake of 0.8-1.0 grams per kilogram of ideal body weight to preserve lean muscle mass during caloric restriction. The clinic emphasizes that GLP-1 medications reduce appetite and slow gastric emptying, but do not replace the need for dietary modification. Typical treatment duration ranges from six to eighteen months, with some patients transitioning to maintenance dosing and others discontinuing peptides after achieving target weight reduction. The clinic provides clear protocols for medication cessation to minimize rebound weight gain, including gradual dose tapering and transition to non-peptide weight maintenance strategies.

Slim Weight Loss Clinic serves patients throughout the Portland metropolitan area who require medical intervention for obesity, defined as BMI of 30 or greater, or BMI of 27 or greater with weight-related comorbidities. The clinic does not treat patients seeking cosmetic weight loss of fewer than 15 pounds or those without documented failed attempts at diet and exercise modification. Insurance verification occurs before the initial appointment, as coverage for weight loss peptides varies significantly among Oregon health plans. Self-pay options exist for patients whose insurance excludes GLP-1 therapies for weight management, with medication costs ranging from $900 to $1,400 monthly depending on the specific peptide prescribed and pharmacy pricing.